A recent study found that certain gene variants may be prognostic for residual disease following resection in patients with ovarian cancer. Whether a patient has residual disease following primary ...
Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement To date 34 patients, or ...
A study found that the difficulty of surgery and the degree of cancer spread in the abdominal cavity can be predicted only by vaginal ultrasound performed before ovarian cancer surgery. The research ...
Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear. We randomly assigned patients with recurrent ...